B
BTIG Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
351
Akebia Therapeutics
AKBA
$785M
|
RH
Robert Hazlett
| $2.96 | $6 |
103%
upside
| Buy | 5 years ago |
|
352
Senseonics Holdings
SENS
$373M
|
MT
Maria Thibault
| $0.4575 | $1 |
119%
upside
| Buy | 5 years ago |
|
353
Amicus Therapeutics
FOLD
$2.46B
|
DGH
Dae Gon Ha
| $7.99 | $19 |
138%
upside
| Buy | 5 years ago |
|
354
Fulcrum Therapeutics
FULC
$414M
|
DGH
Dae Gon Ha
| $7.66 | $27 |
252%
upside
| Buy | 5 years ago |
|
355
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.51B
|
GL
Gregory Lewis
| $28.19 | $40 |
42%
upside
| Buy | 5 years ago |
|
356
BridgeBio Pharma
BBIO
$10.2B
| $53.38 | $49 |
8%
downside
| Buy | 5 years ago |
|
|
357
Viking Therapeutics
VKTX
$3.03B
| $26.98 | $9 |
67%
downside
| Buy | 5 years ago |
|
|
358
Host Hotels & Resorts
HST
$12B
|
JS
James Sullivan
| $17.43 | $16 |
8%
downside
| Buy | 5 years ago |
|
359
Jack in the Box
JACK
$386M
|
PS
Peter Saleh
| $20.43 | $70 |
243%
upside
| Buy | 5 years ago |
|
360
SiTime
SITM
$6.1B
|
MT
Marie Thibault
| $234.77 | $6 |
97%
downside
| Buy | 5 years ago |
|
361
Oportun Financial
OPRT
$289M
|
MP
Mark Palmer
| $6.57 | $19 |
189%
upside
| Buy | 5 years ago |
|
362
Geron
GERN
$893M
|
TS
Thomas Shrader
| $1.40 | $3 |
114%
upside
| Buy | 5 years ago |
|
363
International Money Express
IMXI
$430M
|
MP
Mark Palmer
| $14.48 | $16 |
11%
upside
| Buy | 5 years ago |
|
364
Check Point Software Technologies
CHKP
$20.7B
|
GP
Gray Powell
| $193.09 | $117 |
39%
downside
| Buy | 5 years ago |
|
365
Credit Acceptance
CACC
$5.87B
|
GB
Giuliano Bologna
| $522.61 | $190 |
64%
downside
| Sell | 5 years ago |
|
366
SFL Corp
SFL
$1.09B
| $8.23 | $13 |
58%
upside
| Buy | 5 years ago |
|
|
367
H&R Block
HRB
$6.85B
| $51.13 | $18 |
65%
downside
| Sell | 5 years ago |
|
|
368
FTAI Aviation
FTAI
$15.8B
| $154 | $27 |
82%
downside
| Buy | 5 years ago |
|
|
369
Cerus
CERS
$255M
|
AM
Amanda Murphy
| $1.33 | $7 |
426%
upside
| Buy | 5 years ago |
|
|
CLLS
370
Cellectis
CLLS
$269M
| $2.68 | $39 |
1,355%
upside
| Buy | 5 years ago |
|
|
371
AtriCure
ATRC
$1.76B
|
SL
Sean Lavin
| $35.38 | $48 |
36%
upside
| Buy | 5 years ago |
|
372
NMI Holdings
NMIH
$3.1B
| $39.98 | $41 |
3%
upside
| Buy | 5 years ago |
|
|
373
SS&C Technologies
SSNC
$21.7B
|
MP
Mark Palmer
| $88.80 | $72 |
19%
downside
| Buy | 5 years ago |
|